Helen Louise Collins - 28 Jul 2021 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role
Director
Signature
Marc Grasso, Attorney-in-fact for Helen Collins
Issuer symbol
KURA
Transactions as of
28 Jul 2021
Net transactions value
$0
Form type
4
Filing time
29 Jul 2021, 17:17:06 UTC
Next filing
23 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KURA Option to purchase common stock Award $0 +46,000 $0.000000 46,000 28 Jul 2021 Common Stock 46,000 $18.98 Direct F1
transaction KURA Option to purchase common stock Award $0 +19,166 $0.000000 19,166 28 Jul 2021 Common Stock 19,166 $18.98 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in three equal annual installments commencing on the one year anniversary of the date of grant.
F2 This option vests in full on the one year anniversary of the date of grant.